CLASS II Drug recall · Reported 7 Jun 2017 · FDA Enforcement Report

PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg recalled

SCA Pharmaceuticals is recalling PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentration = 0.1 mg, distributed nationwide in the US. The recall was initiated on 18 May 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT # 20170511@17, Use By: 08/09/17
Quantity recalled30 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0879-2017
FDA event ID
77314
Recalling firm
SCA Pharmaceuticals, Little Rock, AR
Classification
Class II
Status
Terminated
Recall initiated
18 May 2017
FDA classified
31 May 2017
Reported
7 Jun 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

18 May 2017Recall initiated by company
31 May 2017Classified by FDA+13 days
7 Jun 2017Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility: Product bags leaking at seam.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentration = 0.1 mg per mL) Total Volume 100 mL, Single Dose Container bag, Preservative Free (Contains Sulfites), Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC: 70004-0810-32

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Lack of assurance of sterility: Product bags leaking at seam.

Which lots are affected?

LOT # 20170511@17, Use By: 08/09/17

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

9 other products · FDA event 77314

This product is part of a recall event; the main page for the event is ceFAZolin sodium added to 0.9% Sodium Chloride injectable recalled.

More recalls from SCA Pharmaceuticals

All 166

Other Phenylephrine recalls

All 122